4-hydroxycyclophosphamide has been researched along with thiotepa in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, LW; Black, KC; Chen, TL; Colvin, OM; Grochow, LB; Kennedy, MJ; Kiraly, SB | 1 |
| Anderson, LW; Chen, TL; Collins, JM; Colvin, OM; Grochow, LB; Kennedy, MJ; Strong, JM | 1 |
| Armstrong, DK; Chen, TL; Davidson, NE; Goodman, SN; Grochow, L; Hahm, HA; Kennedy, MJ; Passos-Coelho, J | 1 |
| Beijnen, JH; Huitema, AD; Kerbusch, T; Rodenhuis, S; Tibben, MM | 1 |
| Beijnen, JH; Dalesio, O; de Jonge, ME; Huitema, AD; Mathôt, RA; Rodenhuis, S | 1 |
| Beijnen, JH; de Jonge, ME; Huitema, AD; Rodenhuis, S; van Dam, SM | 1 |
2 trial(s) available for 4-hydroxycyclophosphamide and thiotepa
| Article | Year |
|---|---|
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Microsomes, Liver; Middle Aged; Phosphoramide Mustards; Thiotepa | 1996 |
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide | 2005 |
4 other study(ies) available for 4-hydroxycyclophosphamide and thiotepa
| Article | Year |
|---|---|
Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Liver Neoplasms; Middle Aged; Nonlinear Dynamics; Phosphoramide Mustards; Thiotepa | 1997 |
Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 study.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Middle Aged; Novobiocin; Survival Analysis; Thiotepa; Treatment Failure; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |
Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Cyclophosphamide; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Microsomes; Neoplasms; Thiotepa; Time Factors | 2000 |
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thiotepa; Triethylenephosphoramide | 2002 |